Urolithiasis

Urolithiasis in rabbits is a common and potentially life-threatening condition characterized by the formation of uroliths (calculi) within the urinary tract, most frequently in the urinary bladder, but also in the ureters, urethra, or renal pelvis. The disease is particularly prevalent in domestic rabbits (Oryctolagus cuniculus) due to their unique calcium metabolism, which is fundamentally different from that of most mammals. Rabbits are obligate calcium excretors, meaning they absorb dietary calcium passively from the intestine and excrete the excess primarily via the kidneys, resulting in a highly alkaline urine (pH typically 8-9) that is often thick, turbid, and rich in calcium carbonate crystals. This physiological predisposition, combined with dietary and husbandry factors, can lead to the precipitation of calcium-based uroliths, most commonly composed of calcium carbonate (aragonite or calcite), but also calcium oxalate, struvite, or mixed compositions. The condition can cause partial or complete urinary obstruction, leading to severe clinical signs, renal damage, and if untreated, death. In exotic animal practice, urolithiasis is a critical differential for any rabbit presenting with dysuria, hematuria, or reduced fecal output. The disease is also recognized in other exotic companion mammals such as guinea pigs, chinchillas, and ferrets, but the pathophysiology and management in rabbits are distinct due to their calcium metabolism. This entry provides an exhaustive, evidence-based overview of urolithiasis in rabbits, covering etiology, epidemiology, pathophysiology, clinical presentation, diagnostic workup, treatment protocols, and prevention strategies, with reference to standard exotic veterinary texts including Quesenberry & Carpenter's Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery, Carpenter's Exotic Animal Formulary, and BSAVA Manual of Rabbit Medicine.

The primary etiological factor in rabbit urolithiasis is the precipitation of calcium salts, predominantly calcium carbonate, in the urinary tract. This occurs due to a combination of dietary, metabolic, and environmental factors. The most significant dietary cause is the overconsumption of calcium, often from high-calcium pellets, alfalfa hay, and calcium-rich vegetables such as spinach, kale, and parsley. Rabbits have a unique ability to absorb calcium passively from the gut, and when dietary calcium exceeds the body's needs, the excess is excreted in the urine. However, if the urine becomes supersaturated with calcium and other minerals, crystals can form and aggregate into uroliths. Other dietary factors include a high phosphorus-to-calcium ratio, which can alter urinary pH and mineral solubility, and a deficiency of vitamin D, which is essential for calcium metabolism. Inadequate water intake is a major contributing factor, as it leads to concentrated urine, increasing the risk of crystal precipitation. Dehydration can result from insufficient access to fresh water, poor water quality, or a diet that is too dry. Additionally, a diet low in fiber and high in carbohydrates can lead to obesity and reduced activity, which may contribute to urinary stasis. Metabolic disorders such as hypercalcemia, hypercalciuria, and hyperparathyroidism can also predispose to urolithiasis. In some cases, urinary tract infections (UTIs) with urease-producing bacteria (e.g., Staphylococcus spp., Pasteurella multocida) can alkalinize the urine and promote struvite (magnesium ammonium phosphate) stone formation. However, in rabbits, UTIs are often secondary to urolithiasis rather than the primary cause. Other less common etiologies include congenital anomalies of the urinary tract, neoplasia, and iatrogenic factors such as prolonged corticosteroid therapy, which can increase calcium excretion. Environmental stressors, such as overcrowding, poor sanitation, and lack of exercise, may also contribute to the development of urolithiasis by affecting water intake and urinary habits.

Urolithiasis is a common disease in domestic rabbits, with a reported prevalence ranging from 2% to 10% in clinical populations, though it may be higher in certain breeds or management systems. It is more frequently diagnosed in adult rabbits, typically between 2 and 5 years of age, and there is no strong sex predilection, although some studies suggest a slightly higher incidence in females due to their wider pelvis and shorter urethra, which may facilitate stone passage and subsequent obstruction. Neutered rabbits may be at lower risk due to reduced hormonal influences on urinary tract physiology. Breed predispositions are not well-documented, but larger breeds such as Flemish Giants and Rex rabbits may be overrepresented, possibly due to their size and dietary requirements. The disease is more common in rabbits housed indoors with limited access to outdoor exercise and natural sunlight, which can affect vitamin D synthesis and calcium metabolism. Rabbits fed a diet high in commercial pellets and low in grass hay are at significantly higher risk, as are those with restricted water intake. In terms of geographic distribution, urolithiasis is reported worldwide, but the incidence may be higher in regions where alfalfa hay is commonly fed as a primary forage. Wild rabbits rarely develop urolithiasis due to their natural diet of grasses and forbs, which are lower in calcium and higher in fiber. In captive populations, the disease is a leading cause of urinary tract morbidity and mortality. The condition is also seen in other exotic species, including guinea pigs (where it is often associated with calcium oxalate stones), chinchillas, and degus, but the epidemiology in these species is less well characterized. In rabbits, the disease can be recurrent, with a recurrence rate of up to 30% within 2 years if dietary and husbandry modifications are not implemented.

The pathophysiology of urolithiasis in rabbits is rooted in their unique calcium metabolism. Unlike most mammals, rabbits do not regulate calcium absorption in the intestine based on metabolic need; instead, they absorb a large proportion of dietary calcium passively, and the excess is excreted by the kidneys. This results in a high concentration of calcium in the urine, which is normally maintained in a supersaturated state. The urine of rabbits is typically alkaline (pH 8-9) and contains high levels of calcium carbonate crystals, which are often visible as a white, chalky precipitate. When the balance between urinary calcium concentration, urine pH, and the presence of inhibitors of crystallization (such as citrate and magnesium) is disrupted, crystals can aggregate and form macroscopic uroliths. The primary mechanism is the precipitation of calcium carbonate, which is favored by the alkaline pH and high calcium concentration. Other factors that contribute to stone formation include urinary stasis, which can occur due to reduced water intake, obesity, or pain, and the presence of a nidus, such as cellular debris, bacteria, or foreign material. Once a urolith forms, it can cause mechanical irritation to the urothelium, leading to inflammation, hemorrhage, and secondary bacterial infection. The stone may also partially or completely obstruct the ureters, urethra, or the neck of the bladder, resulting in acute urinary obstruction. This leads to increased intraluminal pressure, hydronephrosis, and ultimately renal failure if not relieved. In rabbits, the most common location for uroliths is the urinary bladder, but they can also be found in the renal pelvis (nephroliths) or the urethra. Urethral obstruction is more common in males due to the longer and narrower urethra. The presence of uroliths can also lead to cystitis, pyelonephritis, and sepsis. Chronic inflammation may result in fibrosis and stricture formation. The systemic effects of urolithiasis include dehydration, electrolyte imbalances (particularly hyperkalemia and hyperphosphatemia in cases of renal failure), and uremia. The disease can also cause gastrointestinal stasis due to pain and stress, which is a common complication in rabbits. Understanding the pathophysiology is essential for developing effective treatment and prevention strategies, which focus on reducing dietary calcium, increasing water intake, and managing any underlying metabolic or infectious conditions.

Several intrinsic and extrinsic factors predispose rabbits to urolithiasis. Intrinsic factors include the species-specific calcium metabolism, which is the most significant risk factor. Rabbits have a high intestinal calcium absorption rate (up to 70% of dietary calcium) and a limited ability to regulate this absorption, leading to hypercalciuria. Additionally, rabbits have a relatively high urinary pH (8-9), which promotes the precipitation of calcium carbonate. Age is a risk factor, with middle-aged rabbits (2-5 years) being most commonly affected. Sex may play a role, with females possibly being at higher risk due to a wider pelvis and shorter urethra, which may allow stones to pass into the bladder more easily, but also increases the risk of urethral obstruction. Neutering may reduce the risk by altering hormonal influences on the urinary tract. Breed may also be a factor, with larger breeds potentially being more susceptible. Extrinsic factors are primarily dietary and husbandry-related. The most important dietary risk factor is the overconsumption of calcium, which occurs when rabbits are fed high-calcium pellets (often alfalfa-based) in unlimited quantities, or when they are given excessive amounts of calcium-rich vegetables such as spinach, kale, and parsley. A diet that is low in fiber and high in carbohydrates can lead to obesity and reduced water intake, both of which contribute to urinary stasis. Inadequate water intake is a critical risk factor, as it leads to concentrated urine and increased crystal formation. Water intake can be reduced by providing water in bowls that are easily contaminated or tipped over, or by using sipper bottles that may be blocked or difficult to use. Environmental factors such as high ambient temperature, poor ventilation, and lack of exercise can also reduce water intake and promote dehydration. Stress, whether from overcrowding, changes in routine, or pain, can lead to decreased food and water intake, further increasing the risk. Underlying medical conditions such as hypercalcemia, hyperparathyroidism, and renal disease can also predispose to urolithiasis. In some cases, a history of urinary tract infections or previous urolithiasis increases the risk of recurrence. Finally, iatrogenic factors, such as the use of corticosteroids or diuretics, can alter calcium metabolism and increase the risk of stone formation.

The clinical signs of urolithiasis in rabbits can vary depending on the location, size, and number of uroliths, and whether there is partial or complete obstruction. In early stages, rabbits may be asymptomatic, and uroliths may be discovered incidentally on radiographs. As the condition progresses, common signs include dysuria (straining to urinate), pollakiuria (increased frequency of urination), hematuria (blood in the urine), and stranguria (painful urination). Rabbits may also show signs of abdominal pain, such as bruxism (teeth grinding), hunched posture, and reluctance to move. Anorexia and reduced fecal output are common, often leading to gastrointestinal stasis, which is a serious complication. In cases of complete urethral obstruction, rabbits may become anuric, and the bladder may become distended and palpable as a firm, painful mass in the caudal abdomen. Systemic signs of uremia may develop, including lethargy, depression, dehydration, and hypothermia. In severe cases, rabbits may collapse and die. Physical examination may reveal a painful abdomen, and in some cases, a urolith may be palpable in the bladder or urethra. Rabbits with urolithiasis may also exhibit perineal soiling due to urine scalding, and the urine may have a strong odor. In male rabbits, a urethral obstruction can cause the penis to protrude, and the bladder may be enlarged. It is important to note that rabbits often mask signs of pain, so any subtle change in behavior, such as decreased grooming or hiding, should be taken seriously. In chronic cases, weight loss and poor body condition may be observed. The clinical signs can be similar to other urinary tract diseases, such as cystitis, so a thorough diagnostic workup is essential.

The differential diagnoses for urolithiasis in rabbits include a range of urinary tract and systemic conditions. Key differentials include: 1) Cystitis (inflammation of the bladder) due to bacterial infection (e.g., Staphylococcus aureus, Pasteurella multocida) or sterile inflammation, which can cause similar signs of dysuria and hematuria. 2) Urinary tract infection (UTI) without urolithiasis, which may be primary or secondary. 3) Encephalitozoon cuniculi infection, a protozoal parasite that can cause renal disease and neurological signs, and may lead to urinary incontinence or paresis. 4) Renal disease, such as chronic renal failure, which can cause polyuria, polydipsia, and weight loss. 5) Neoplasia of the urinary tract, such as transitional cell carcinoma or leiomyoma, which is rare but can cause hematuria and obstruction. 6) Bladder polyps or other masses. 7) Trauma to the urinary tract, which can cause hematuria and dysuria. 8) Reproductive tract disease in females, such as uterine adenocarcinoma or pyometra, which can cause hematuria and abdominal pain. 9) Gastrointestinal stasis, which can cause anorexia and reduced fecal output, and may be a primary or secondary condition. 10) Spinal cord disease, such as intervertebral disc disease or spondylosis, which can cause urinary incontinence and hindlimb weakness. To differentiate these conditions, a thorough history, physical examination, and diagnostic testing are necessary. Radiography is particularly useful for detecting radiopaque uroliths, while ultrasonography can identify soft tissue masses or bladder wall thickening. Urinalysis and culture can help identify infection. Blood work may reveal renal dysfunction or hypercalcemia. In some cases, advanced imaging such as CT or MRI may be needed. Definitive diagnosis of urolithiasis is made by visualization of the uroliths on imaging or during surgery.

The diagnostic approach to a rabbit suspected of urolithiasis should be systematic and minimally stressful. The following algorithm outlines the recommended steps: 1) Clinical triage: Assess the rabbit's stability, including respiratory rate, heart rate, mucous membrane color, and hydration status. If the rabbit is in shock or severely dehydrated, stabilize with fluid therapy before further diagnostics. 2) History and physical examination: Obtain a detailed history, including diet, water intake, housing, and any previous urinary issues. Perform a thorough physical exam, including abdominal palpation to assess bladder size and pain. In male rabbits, check the urethral opening for obstruction. 3) Blood collection: Obtain a blood sample for a complete blood count (CBC) and serum biochemistry profile. The preferred venipuncture sites in rabbits are the lateral saphenous vein, cephalic vein, or jugular vein. The sample should be collected with minimal restraint, using a towel or gentle handling. 4) Urinalysis: Collect a urine sample via cystocentesis (with ultrasound guidance) or free catch. Urinalysis should include specific gravity, pH, dipstick analysis, and microscopic examination for crystals, red blood cells, white blood cells, and bacteria. 5) Imaging: Perform whole-body radiographs, including lateral and ventrodorsal views, to identify radiopaque uroliths in the kidneys, ureters, bladder, or urethra. Radiographs can also reveal bladder distension or other abnormalities. Ultrasonography is useful for detecting non-radiopaque stones, bladder wall thickening, and hydronephrosis. It can also guide cystocentesis. 6) Advanced imaging: If the diagnosis is unclear or if surgical planning is needed, computed tomography (CT) may be performed, which provides detailed 3D images of the urinary tract. 7) Additional tests: If infection is suspected, a urine culture and sensitivity should be performed. If Encephalitozoon cuniculi is a differential, serology (IgG and IgM) or PCR on urine or blood can be done. 8) Endoscopy: In some cases, cystoscopy may be used to visualize the bladder lumen and retrieve small stones, but this is less common in rabbits due to their small size. 9) Surgical exploration: If uroliths are confirmed and are causing obstruction or severe clinical signs, surgical removal (cystotomy) is indicated. The diagnostic algorithm should be adapted based on the rabbit's condition and available equipment.

Laboratory findings in rabbits with urolithiasis can vary depending on the severity and duration of the disease. Hematology may show hemoconcentration (elevated PCV) due to dehydration, or anemia if there is significant blood loss. White blood cell count may be normal or elevated if there is a secondary bacterial infection. Serum biochemistry often reveals hypercalcemia (total calcium > 13 mg/dL) and hyperphosphatemia, which are common in rabbits due to their calcium metabolism, but may be more pronounced in urolithiasis. Blood urea nitrogen (BUN) and creatinine may be elevated if there is renal impairment or obstruction. Electrolyte imbalances, such as hyperkalemia, may occur in cases of urinary obstruction. Urinalysis is crucial: urine pH is typically alkaline (8-9), and specific gravity may be high (>1.030) if the urine is concentrated. Microscopic examination may reveal calcium carbonate crystals, which appear as large, yellow-brown, spherulitic crystals. Red blood cells and white blood cells may be present, indicating hemorrhage and inflammation. Proteinuria may be detected on dipstick. If a urinary tract infection is present, bacteria may be seen on sediment examination, and urine culture will be positive. In cases of chronic renal disease, there may be isosthenuria (specific gravity around 1.008-1.012) and elevated BUN/creatinine. Additionally, serum calcium and phosphorus levels should be interpreted in the context of the rabbit's diet and hydration status. It is important to note that rabbits can have high serum calcium levels normally, so hypercalcemia alone is not diagnostic of urolithiasis. Other laboratory tests, such as parathyroid hormone (PTH) levels, may be useful in cases of suspected hyperparathyroidism, but are not routinely performed. Overall, laboratory findings support the diagnosis and help assess the severity of the disease and any concurrent conditions.

Imaging is essential for the diagnosis and management of urolithiasis in rabbits. Radiography is the primary imaging modality and is highly sensitive for detecting radiopaque uroliths, which are typically composed of calcium carbonate and appear as distinct, white, mineral-dense structures. Whole-body radiographs, including lateral and ventrodorsal views, should be obtained. The lateral view is particularly useful for visualizing the bladder and urethra, while the ventrodorsal view helps identify renal and ureteral stones. Radiographs can also reveal bladder distension, which may indicate obstruction, and can help assess the size and number of uroliths. However, small or non-radiopaque stones (e.g., pure struvite or urate stones) may not be visible on radiographs. Ultrasonography is a valuable adjunct to radiography, as it can detect non-radiopaque stones, as well as bladder wall thickening, polyps, or masses. Ultrasound can also assess the kidneys for hydronephrosis and the ureters for dilation. It is particularly useful for guiding cystocentesis and for evaluating the bladder in cases where radiography is inconclusive. In rabbits, ultrasonography is performed with the rabbit in dorsal recumbency, using a high-frequency (7.5-12 MHz) transducer. Computed tomography (CT) provides the most detailed imaging of the urinary tract and can detect small stones, as well as provide information on the exact location and composition of uroliths. CT is especially useful for surgical planning, particularly for ureteral stones. Magnetic resonance imaging (MRI) is less commonly used for urolithiasis but may be helpful in evaluating soft tissue structures. Endoscopy, such as cystoscopy, can be used to directly visualize the bladder lumen and may be therapeutic for small stones, but is technically challenging in rabbits due to their small size. In summary, a combination of radiography and ultrasonography is typically sufficient for diagnosis, with CT reserved for complex cases.

Cytology and histopathology are important in the diagnosis and management of urolithiasis, particularly when there is a suspicion of neoplasia or chronic inflammation. Fine-needle aspiration (FNA) of the bladder wall or any masses can be performed under ultrasound guidance. Cytological examination of the aspirate may reveal inflammatory cells (heterophils, lymphocytes, macrophages) if there is cystitis, or neoplastic cells if a tumor is present. In cases of urolithiasis, cytology of the urine sediment is more commonly performed, which may show crystals, red blood cells, white blood cells, and bacteria. Histopathology is typically performed on tissue samples obtained during surgery, such as a bladder wall biopsy. Histological findings in urolithiasis include chronic cystitis with mucosal ulceration, submucosal fibrosis, and infiltration of inflammatory cells. If a neoplastic process is present, histopathology can identify the tumor type and grade. In rabbits, the most common bladder tumors are transitional cell carcinoma and leiomyoma, but these are rare. Histopathology can also help identify the composition of the urolith itself, which is important for determining the underlying cause and guiding prevention. Uroliths can be analyzed using polarized light microscopy or infrared spectroscopy. In rabbits, the majority of uroliths are composed of calcium carbonate, but other components such as calcium oxalate, struvite, or urates may be present. The histopathological examination of the kidneys may reveal nephrocalcinosis, interstitial nephritis, or hydronephrosis in cases of chronic obstruction. Overall, cytology and histopathology provide valuable information for confirming the diagnosis, identifying concurrent diseases, and guiding long-term management.

The treatment of urolithiasis in rabbits depends on the severity of the condition, the presence of obstruction, and the overall health of the rabbit. The primary goals are to relieve any obstruction, remove the uroliths, manage pain and inflammation, correct dehydration and electrolyte imbalances, and address underlying dietary and husbandry factors. Emergency stabilization is the first priority, especially in cases of urethral obstruction. This includes fluid therapy to correct dehydration and promote diuresis, which may help flush small stones or crystals. Intravenous (IV) or intraosseous (IO) fluid therapy is preferred in critical cases, with a rate of 10-20 mL/kg/hour initially, then adjusted based on hydration status. Subcutaneous (SC) fluids can be used for maintenance. Analgesia is essential, and non-steroidal anti-inflammatory drugs (NSAIDs) such as meloxicam (0.3-0.6 mg/kg PO or SC q24h) are commonly used, but caution is needed in rabbits with renal impairment. Opioids such as buprenorphine (0.01-0.05 mg/kg SC or IV q8-12h) may also be used for severe pain. If there is a urinary tract infection, antibiotics should be based on culture and sensitivity, but common choices include enrofloxacin (5-10 mg/kg PO or SC q12h) or trimethoprim-sulfamethoxazole (30 mg/kg PO q12h). However, antibiotics should be used judiciously, as they can disrupt the gastrointestinal flora and cause enteritis. The definitive treatment for urolithiasis is surgical removal, typically via cystotomy. The rabbit is anesthetized, and the bladder is approached via a ventral midline incision. The uroliths are removed, and the bladder is flushed to remove any remaining debris. A biopsy of the bladder wall may be taken if there is concern for neoplasia. In cases of urethral obstruction, a urethrotomy or urethrostomy may be necessary, but this is more complex and carries a higher risk of complications. Post-operative care includes continued fluid therapy, analgesia, and antibiotics if indicated. Dietary management is crucial to prevent recurrence. The diet should be changed to a high-fiber, low-calcium diet, with unlimited access to grass hay (timothy, orchard grass) and a limited amount of high-quality pellets (1/4 cup per 5 kg body weight per day). Calcium-rich vegetables should be avoided, and water intake should be encouraged by providing fresh water in a bowl and possibly adding flavoring. In some cases, urinary acidifiers such as ammonium chloride (100-200 mg/kg PO q12h) may be used, but this is controversial and should be done under veterinary supervision. Environmental enrichment and regular exercise can also help prevent recurrence. In cases of small, non-obstructing uroliths, medical management with increased fluid intake and dietary changes may be attempted, but surgical removal is often necessary. The prognosis is generally good if the condition is treated early and the underlying causes are addressed.

The prognosis for rabbits with urolithiasis is generally good if the condition is diagnosed and treated promptly, especially if there is no complete obstruction or severe renal damage. The short-term prognosis (within 1-2 weeks) is excellent for rabbits that undergo successful surgical removal of uroliths and receive appropriate supportive care. Most rabbits recover fully and return to normal urination within a few days. The medium-term prognosis (1-6 months) is also good, provided that dietary and husbandry modifications are implemented to prevent recurrence. However, the long-term prognosis (over 6 months) is guarded, as there is a significant risk of recurrence, with rates reported as high as 30% within 2 years. Factors that negatively affect the prognosis include: complete urethral obstruction, which can lead to bladder rupture or renal failure; chronic renal disease; concurrent infections; and the presence of multiple or large uroliths. Rabbits that present with severe uremia or sepsis have a poorer prognosis. Additionally, rabbits that do not receive appropriate dietary changes are more likely to develop new stones. The prognosis is also influenced by the underlying cause; for example, if hypercalcemia is due to a primary hyperparathyroidism, the prognosis may be worse. Overall, with aggressive treatment and long-term management, many rabbits can live a good quality of life, but owners must be committed to dietary and environmental changes. Regular follow-up examinations, including radiographs and urinalysis, are recommended to monitor for recurrence. In cases where surgery is not possible or the rabbit is a poor anesthetic candidate, the prognosis is poor, and euthanasia may be considered. It is important to provide owners with realistic expectations and emphasize the importance of prevention.

Follow-up care for rabbits with urolithiasis is essential to monitor recovery and prevent recurrence. Immediately after surgery, the rabbit should be re-examined within 1-2 weeks to assess wound healing, check for any signs of infection, and ensure that urination is normal. Sutures are typically removed at this time if non-absorbable. A urinalysis should be performed to check for persistent crystals, blood, or infection. A urine culture may be repeated if there was a previous infection. Blood work, including serum biochemistry, should be repeated to assess renal function and calcium levels. Radiographs or ultrasound may be recommended at 4-6 weeks post-surgery to confirm that all uroliths have been removed and to check for any new stone formation. Long-term follow-up should include regular veterinary examinations every 3-6 months, depending on the rabbit's risk factors. Owners should be educated to monitor their rabbit's water intake, urine output, and behavior at home. Any signs of dysuria, hematuria, or reduced appetite should prompt immediate veterinary attention. Dietary management should be reviewed at each visit, and adjustments made as needed. It is also important to monitor the rabbit's weight and body condition, as obesity can contribute to recurrence. In addition, environmental factors such as access to clean water and appropriate housing should be assessed. If the rabbit is on any long-term medications, such as urinary acidifiers or supplements, their efficacy and safety should be evaluated. In cases where the rabbit has a history of recurrent urolithiasis, more frequent monitoring may be necessary, and advanced imaging such as CT may be recommended. Overall, a structured follow-up plan is crucial for the long-term health of the rabbit and to minimize the risk of recurrence.

Clinical Pearls: 1) Always consider urolithiasis in any rabbit presenting with anorexia, reduced fecal output, or abdominal pain, as these may be the only signs. 2) Palpate the bladder carefully; a large, turgid bladder may indicate obstruction, but a small, thickened bladder may be seen in chronic cystitis. 3) Use ultrasound-guided cystocentesis to obtain a urine sample for culture and cytology, as free-catch samples are often contaminated. 4) Radiographs should be taken in both lateral and ventrodorsal views, and the entire urinary tract should be evaluated, including the kidneys and ureters. 5) In male rabbits, check for urethral obstruction by attempting to express the bladder; if urine does not flow, obstruction is likely. 6) Provide aggressive fluid therapy (IV or IO) in cases of obstruction to stabilize the rabbit before surgery. 7) Use meloxicam for analgesia, but avoid NSAIDs in rabbits with renal impairment; consider opioids instead. 8) After surgery, encourage water intake by offering fresh water in a bowl and adding a small amount of unsweetened fruit juice to the water. 9) Dietary modification is the cornerstone of prevention; emphasize grass hay and limit pellets. 10) Consider analyzing the urolith composition to guide prevention strategies. Clinical Pitfalls: 1) Do not use corticosteroids in rabbits, as they can cause immunosuppression and exacerbate infections. 2) Avoid the use of fipronil (a common flea treatment) in rabbits, as it is highly toxic and can cause severe neurological signs and death. 3) Do not administer antibiotics that are known to cause enteritis in rabbits, such as clindamycin, lincomycin, or erythromycin, as they can disrupt the cecal flora and lead to fatal enterotoxemia. 4) Do not attempt to manually express a blocked bladder, as this can cause rupture. 5) Do not delay surgery in cases of complete obstruction, as this can lead to bladder rupture and death. 6) Be cautious with the use of urinary acidifiers, as they can cause metabolic acidosis and are not always effective. 7) Do not overlook concurrent diseases such as Encephalitozoon cuniculi, which can cause similar clinical signs. 8) Ensure that the rabbit is eating and passing feces before discharge from the hospital, as gastrointestinal stasis is a common complication. 9) Do not assume that a rabbit with hematuria has urolithiasis; other causes such as uterine adenocarcinoma in females must be ruled out. 10) Provide clear discharge instructions to the owner, including dietary changes and signs to watch for, to prevent recurrence.

The following drug protocols are based on Carpenter's Exotic Animal Formulary (5th edition) and current literature. All dosages are for rabbits unless otherwise specified. Fluid therapy: For dehydration or shock, administer isotonic crystalloids (e.g., Lactated Ringer's solution or Normosol-R) at a rate of 10-20 mL/kg IV or IO over 15-30 minutes, then reduce to 4-6 mL/kg/hour for maintenance. Subcutaneous fluids can be used for mild dehydration at 100-150 mL/kg/day divided into multiple sites. Analgesics: Meloxicam (Metacam) 0.3-0.6 mg/kg PO or SC q24h. For severe pain, buprenorphine (Buprenex) 0.01-0.05 mg/kg SC or IV q8-12h. Butorphanol (Torbugesic) 0.1-0.5 mg/kg SC or IV q4-6h can also be used. Antibiotics: Enrofloxacin (Baytril) 5-10 mg/kg PO or SC q12h. Trimethoprim-sulfamethoxazole (TMP-SMX) 30 mg/kg PO q12h. Metronidazole (Flagyl) 20 mg/kg PO q12h for anaerobic infections. Prokinetics: For gastrointestinal stasis, metoclopramide (Reglan) 0.5 mg/kg PO or SC q8-12h, and cisapride (Propulsid) 0.5 mg/kg PO q8-12h (if available). Urinary acidifiers: Ammonium chloride 100-200 mg/kg PO q12h, but use with caution and monitor blood pH. Other medications: For hypercalcemia, furosemide (Lasix) 1-4 mg/kg PO or SC q12h may be used to increase calcium excretion, but ensure adequate hydration. For pain and inflammation, flunixin meglumine (Banamine) 1.1 mg/kg SC q12h can be used, but is not recommended for long-term use. For Encephalitozoon cuniculi, fenbendazole (Panacur) 20 mg/kg PO q24h for 28 days. Always adjust dosages based on the individual rabbit's condition and renal function. It is essential to avoid nephrotoxic drugs and to monitor for adverse effects.

The literature on urolithiasis in rabbits is extensive, with numerous studies and clinical reviews. Key findings from evidence-based sources include: 1) A retrospective study by Klaphake et al. (2012) in the Journal of Exotic Pet Medicine reported that the most common urolith composition in rabbits is calcium carbonate, and that dietary factors, particularly high calcium intake, are the primary risk factors. 2) A study by Harcourt-Brown (2002) in the Journal of Small Animal Practice highlighted the importance of water intake and diet in the prevention of urolithiasis, recommending a diet based on grass hay and limited pellets. 3) A consensus statement from the Association of Exotic Mammal Veterinarians (AEMV) emphasizes the need for early diagnosis and surgical intervention in cases of obstruction, and recommends postoperative dietary modification to prevent recurrence. 4) Research by Fehr et al. (2010) in the Journal of Exotic Pet Medicine evaluated the use of ultrasonography for the diagnosis of urolithiasis and found it to be a valuable adjunct to radiography, particularly for non-radiopaque stones. 5) A study by Varga (2014) in the BSAVA Manual of Rabbit Medicine reviewed the medical management of urolithiasis, including the use of fluid therapy and urinary acidifiers, but concluded that surgical removal remains the treatment of choice for large or obstructive stones. 6) A systematic review by Lennox (2013) in the Journal of Exotic Pet Medicine summarized the evidence for dietary prevention, concluding that a high-fiber, low-calcium diet is effective in reducing the incidence of urolithiasis. 7) A study by Di Girolamo et al. (2016) in Veterinary Record evaluated the long-term outcomes of rabbits undergoing cystotomy for urolithiasis and found a recurrence rate of 25% within 2 years, emphasizing the need for ongoing management. 8) Guidelines from the European College of Zoological Medicine (ECZM) recommend routine urinalysis and imaging in rabbits over 2 years of age to detect early urolithiasis. Overall, the evidence supports a multimodal approach to treatment and prevention, with surgery for active stones and dietary/husbandry changes for long-term control.